Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03736057 · ClinicalTrials.gov registry record
Genetic Evaluation for Medication Selection (GEMS) Study
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 40
- Enrollment target
NCT03736057: Completed study, sponsored by University of Alabama at Birmingham.
NCT03736057 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03736057 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
Investigators propose to determine whether knowing details about how a person's genes affect the way medicines work in the brain and body will help doctors pick more effective or safer medicine for that person. Target symptoms are restlessness, agitation, depression and related problems common in people with memory loss and dementia.
Primary Outcome
Comparison from baseline Neuropsychiatric Inventory-Questionnaire (NPI-Q) and the 12-week follow-up. Neuropsychiatric Inventory-Questionnaire is a questionnaire completed by caregivers about patients designed to measure both neuropsychiatric symptoms (e.g., agitation/aggression, anxiety, hallucinations). There are 12 symptoms included in NPI-Q. Each domain includes an initial response of "yes" or "no". If "yes", then the caregiver rates the severity of the symptom on a 3-point scale (1= mild, 2
Interventions
- OTHER Delayed results of pharmacogenomic results
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-05-13 |
| Est. Completion | 2018-08-14 |
What the finished NCT03736057 record still lists
NCT03736057 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Delayed results of pharmacogenomic results is the first listed.
NCT03736057 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03736057 about?
NCT03736057 is a clinical study titled "Genetic Evaluation for Medication Selection (GEMS) Study". Investigators propose to determine whether knowing details about how a person's genes affect the way medicines work in the brain and body will help doctors pick more effective or safer medicine for that person. Target symptoms are restlessness, agitation, depression and related problems common in pe...
What is the current status of trial NCT03736057?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2016-05-13. Estimated completion is 2018-08-14.
What interventions are being tested in trial NCT03736057?
The interventions under investigation include: Delayed results of pharmacogenomic results (OTHER).
Who is sponsoring clinical trial NCT03736057?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI